PYNG MEDICAL CORP ........ ::

Kosmonova buran  

http://www.ariva.de/pyng_medical_corp-aktie/chart GrB  

http://www.ariva.de/pyng_medical_corp-aktie/historische_kurse GrB  

http://www.ariva.de/extras/lexikon.m GrB  

::::::::: ENTER  

http://www.ariva.de/pyng_medical_corp-aktie GrB  

..Du Sie Du  

Mailing Address: Unit 210, 13480 Crestwood Place
Richmond, British Columbia
V6V 2J9
Head Office Address: Unit 210, 13480 Crestwood Place
Richmond, British Columbia
V6V 2J9
Contact Name: Mark F. Hodge Principal Regulator: British Columbia
Business e-mail address: info@pyng.com Short Form Prospectus Issuer: No
Telephone Number: 604 303-7964 Reporting Jurisdictions: British Columbia, Alberta
Fax Number: 604 303-7987 Stock Exchange: TSX Venture
Date of Formation: May 15 1987 Stock Symbol: PYT
Jurisdiction Where Formed: British Columbia Auditor: Morgan & Company
Industry Classification: junior industrial General Partner:
CUSIP Number: 746908 Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Sep 30 Size of Issuer (Assets): $5,000,001 to $25,000,000
http://www.sedar.com/...ng=EN&issuerType=03&issuerNo=00007496  

http://www.sedar.com/...ng=EN&issuerType=03&issuerNo=00007496 GrB  

direction of the Board of Directors, whose purpose is to maximize long-term economic value for our shareholders by responsibly addressing the concerns of our employees, business partners, communities, and government. Pyng has adopted corporate governance practices to promote the effective functioning of the Board, its committees and the company. All employees, officers and directors are required to adhere to principals of integrity and honesty while conducting business on behalf of Pyng Medical Corporation. http://www.pyng.com/about-us/investors/
 

Intelligence on Pyng Medical Corp. here. http://www.pyng.com/about-us/investors/
 

Pyng Medical Corp. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Pyng Medical’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pyng Medical or its management. Pyng Medical does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. http://www.pyng.com/about-us/investors/
 

reports are filed online with SEDAR (System for Electronic Document Analysis and Retrieval). http://www.pyng.com/about-us/investors/
 

http://www.pyng.com/about-us/investors/ GrB  

VANCOUVER, BRITISH COLUMBIA–(Marketwired – July 2, 2015) - Pyng Medical Corp. (TSX VENTURE:PYT) (the “Company” or “Pyng“) announces that on July 1, 2015 it granted a total of 315,000 options to purchase common shares of the Company to certain Directors and Officers as well as an Advisory Board Member of the Company in accordance with the Company’s stock option plan dated March 18, 2005, as amended and restated on March 5, 2008 and March 31, 2011. The options will vest immediately, expire on July 1, 2019 and have an exercise price of $0.05 per common share.
The Company has determined that the exemptions from the various requirements of the TSX Venture Exchange Policies are available for the granting of these options. http://www.pyng.com/...dical-corp-announces-grant-of-stock-options-6/  

Pyng Medical is a medical device company focused on the research, development, manufacturing and distribution of life-saving trauma and resuscitation devices in three main product categories:
Sternal Intraosseous Infusion: FASTResponder, FASTCombat, FAST1
Pelvic Stabilization: T-PODResponder, T-PODCombat
Tourniquets for Blood Flow Occlusion: MATResponder, MATCombat
Based in Richmond, British Columbia, Pyng was founded in the 1990’s and today has a lean and dedicated team of medical, engineering, education, and training professionals.
Pyng’s medical devices are brought to market through a global network of specialty medical device distributors. http://www.pyng.com/about-us/  

:::::::::::: 0,0321 $ 0,00% +0,00 $
In Euro: 0,0298 € | Nasdaq OTC Other, 13.10.15 ,GrB  

:::::::::::: 0,05 $ +82,48% +0,0226 $
In Euro: 0,0459 € | Nasdaq OTC Other, 14.01.16 ,GrB  

::::::::::::: 0,0595 $ +19,00% +0,0095 $
In Euro: 0,0527 € | Nasdaq OTC Other, 28.01.16 ,GrB  

Zeit      Kurs Stück
  20:36:24§0,041 $ 2.000
___________________
GRATULATION  

::::::::::: 0,041 $ +0,49% +0,0002 $
In Euro: 0,0363 € | 13.04.16 Nasdaq OTC Other ,GrB  

Datum Erster Hoch Tief Schluss Stücke Volumen
  06.05.16    0,0406    0,0406§0,0406 0,0406 $ 1.000 41

GrB  

http://www.ariva.de/pyng_medical_corp.-aktie/kurs GrB  

7 REASONS TO CHOOSE THE FASTTACTICAL STERNAL IO DEVICE FOR YOUR MILITARY OR EMS TEAM
By Pyng Medical | FASTTactical | 0 Comments

When seconds count, you need an Intraosseous Infusion route and device that will enable you to get critical fluids and medications into the bloodstream as quickly and reliably as possible.  http://go.pyng.com/blog  

kein aktueller Kurs verfügbar ,GrB